ELZA at OPT-X.25
The ELZA team presented at OPT-X.25 in Baden, showcasing our Zurich keratoconus treatment expertise from diagnostics and contact lenses to advanced surgical care
Mark Hillen
September 23, 2025
The ELZA team presented at OPT-X.25 in Baden, showcasing our Zurich keratoconus treatment expertise from diagnostics and contact lenses to advanced surgical care
By offering a non-surgical option that improves vision and comfort, mini scleral contact lenses can enhance the quality of life for patients with otherwise challenging visual impairments. Future research could further explore long-term outcomes and compare mini scleral contact lenses with other rehabilitative options to solidify their role in ophthalmic care.
Explore the journey of ELZA Institute’s Lead Optometrist, Léonard Kollros, MSc, in earning the distinguished Fellow of the Scleral Lens Education Society (FSLS) title, underscoring his expertise in managing keratoconus with scleral lenses.
Many women with endometriosis receive “selective tissue estrogenic activity regulator” (STEAR) therapy, but this treatment can cause previously stable keratoconus to start progressing – rapidly
ELZA’s Medical Director, Prof. Farhad Hafezi was an invited international guest speaker at the recent 13th Congrès D’Ophthalmologique Practique (AOPA) at the Hotel Sheraton Alger in Algiers. The congress covered all of ophthalmology, but had a large cornea and refractive sessions, where Prof. Hafezi gave presentations on ELZA’s current research work. His podium presentations reviewed ELZA’s research into refractive surgery, corneal cross-linking and PACK-CXL for the treatment of corneal infection. He also celebrated his birthday while attending the congress!
